175277-39-1 Usage
Description
PYRROLIDINE-1-CARBOXIMIDAMIDE HYDROBROMIDE, also known as PCCA hydrobromide, is a chemical compound that serves as a salt form of pyrrolidone carboxamide. It is a derivative of gamma-aminobutyric acid (GABA) and has been studied for its potential as a central nervous system depressant. This versatile chemical is commonly used in pharmaceutical and research applications, playing a significant role in the development and production of pharmaceutical drugs and treatments.
Uses
Used in Pharmaceutical Synthesis:
PYRROLIDINE-1-CARBOXIMIDAMIDE HYDROBROMIDE is used as a precursor in the synthesis of various pharmaceuticals for its potential role in the development of new drugs and treatments.
Used in Research Applications:
PYRROLIDINE-1-CARBOXIMIDAMIDE HYDROBROMIDE is used as a research chemical to study its properties and potential applications in the field of neuroscience and pharmacology.
Used in Treatment of Neurological Disorders:
PYRROLIDINE-1-CARBOXIMIDAMIDE HYDROBROMIDE is used as a potential therapeutic agent for the treatment of neurological disorders and mood-related conditions due to its relationship with gamma-aminobutyric acid (GABA), a key neurotransmitter in the central nervous system.
It is crucial to handle and store PYRROLIDINE-1-CARBOXIMIDAMIDE HYDROBROMIDE with caution and in accordance with proper safety protocols to ensure the safety of researchers and the effectiveness of its applications.
Check Digit Verification of cas no
The CAS Registry Mumber 175277-39-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,2,7 and 7 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 175277-39:
(8*1)+(7*7)+(6*5)+(5*2)+(4*7)+(3*7)+(2*3)+(1*9)=161
161 % 10 = 1
So 175277-39-1 is a valid CAS Registry Number.
InChI:InChI=1/C5H11N3.BrH/c6-5(7)8-3-1-2-4-8;/h1-4H2,(H3,6,7);1H
175277-39-1Relevant articles and documents
ANTIVIRAL PYRIMIDINES
-
Page/Page column 57, (2010/11/03)
Disclosed herein are novel compounds comprising substituted pyrimidines, pyrazolopyrimtdines, and imidazolopyrimidines, the syntheses thereof, and compositions thereof, including pharmaceutical compositions, comprising the novel pyrimidines, pyrazolopyrimtdines, imidazolpyrimidines and related compounds. Such compounds function to inhibit entry of viruses of the Flaviviridae family, including Hepatitis C virus (HCV), into cells that are susceptible to virus infection. These compounds are useful for the treatment, therapy and/or prophylaxis of viral diseases and infection, including HCV infection.
Xi:Irritant;
